Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pan-RAF Kinase Inhibitor TAK-580

Known as: MLN-2480, TAK580, MLN2480 
An orally available inhibitor of A-Raf, B-Raf and C-Raf protein kinases, with potential antineoplastic activity. Upon administration, pan-RAF kinase… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Targeted inhibition of RAF and MEK by molecularly targeted agents has been employed as a strategy to block aberrant mitogen… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2017
2017
Background Activating mutations or structural rearrangements in BRAF are identified in roughly 75% of all pediatric low-grade… Expand
  • figure 4
Is this relevant?
2015
2015
TPS2609 Background: Signaling hyperactivation secondary to MAPK pathway aberrations are common. RAF kinases play key roles in the… Expand
Is this relevant?
2013
2013
2547 Background: MLN2480 is an investigational pan-RAF kinase inhibitor. In vivo, MLN2480 showed antitumor activity in melanoma… Expand
Is this relevant?